Studies Involving Masitinib Suspended

Studies Involving Masitinib Suspended

295688

Studies Involving Masitinib Suspended

AB Science will suspend recruitment and treatment in all studies involving masitinib, a tyrosine kinase inhibitor being investigated for amyotrophic lateral sclerosis (ALS) and several other conditions. The voluntary suspension follows the identification of a potential risk of ischemic heart disease — a condition of recurring chest pain or discomfort — associated with masitinib use. AB Science is filing for a temporary hold on all ongoing studies, including a Phase 3 clinical trial in ALS…

You must be logged in to read/download the full post.